Consilium Wealth Advisory LLC lifted its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 3.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,096 shares of the company’s stock after purchasing an additional 96 shares during the period. Consilium Wealth Advisory LLC’s holdings in Procter & Gamble were worth $528,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. Cladis Investment Advisory LLC raised its stake in Procter & Gamble by 5.2% in the fourth quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company’s stock worth $806,000 after buying an additional 236 shares in the last quarter. FAS Wealth Partners Inc. raised its stake in Procter & Gamble by 2.0% in the fourth quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company’s stock worth $4,642,000 after buying an additional 549 shares in the last quarter. Berkshire Asset Management LLC PA raised its stake in Procter & Gamble by 0.9% in the fourth quarter. Berkshire Asset Management LLC PA now owns 236,616 shares of the company’s stock worth $38,833,000 after buying an additional 2,179 shares in the last quarter. Strategic Advisors LLC raised its stake in Procter & Gamble by 3.4% in the fourth quarter. Strategic Advisors LLC now owns 55,912 shares of the company’s stock worth $9,374,000 after buying an additional 1,818 shares in the last quarter. Finally, Natural Investments LLC bought a new position in Procter & Gamble in the fourth quarter worth approximately $2,121,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Price Performance
NYSE PG opened at $160.79 on Tuesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The stock’s fifty day moving average price is $163.81 and its 200 day moving average price is $166.51. The Procter & Gamble Company has a 1 year low of $156.58 and a 1 year high of $180.43. The company has a market cap of $376.99 billion, a price-to-earnings ratio of 25.60, a PEG ratio of 3.76 and a beta of 0.43.
Procter & Gamble Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Monday, April 21st were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.63%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.01. The ex-dividend date was Monday, April 21st. Procter & Gamble’s dividend payout ratio is presently 66.98%.
Insider Buying and Selling at Procter & Gamble
In other news, CEO Jennifer L. Davis sold 1,000 shares of the stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the sale, the chief executive officer now directly owns 51,965 shares of the company’s stock, valued at $8,386,111.70. This represents a 1.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the sale, the insider now directly owns 25,182 shares in the company, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.18% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on PG shares. Citigroup reduced their price objective on shares of Procter & Gamble from $200.00 to $181.00 and set a “buy” rating for the company in a research note on Friday, April 25th. Bank of America reduced their price objective on shares of Procter & Gamble from $190.00 to $180.00 and set a “buy” rating for the company in a research note on Friday, April 25th. Barclays reaffirmed an “equal weight” rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Redburn Partners set a $161.00 price target on Procter & Gamble in a research report on Thursday, May 1st. Finally, Redburn Atlantic downgraded Procter & Gamble from a “buy” rating to a “neutral” rating and set a $161.00 price target on the stock. in a research report on Thursday, May 1st. Eight research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $178.86.
Check Out Our Latest Stock Analysis on PG
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- The How And Why of Investing in Oil Stocks
- New Catalysts to Drive NVIDIA’s Stock Price Even Higher
- Comparing and Trading High PE Ratio Stocks
- China Market Movers: MCHI, PDD, BIDU Show Bullish Trends
- Golden Cross Stocks: Pattern, Examples and Charts
- Palantir Defies Bears, Leads S&P 500 in 2025
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.